UNICA IRIS Institutional Research Information System

CARPINIELLO, BERNARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 360.675
NA - Nord America 27.766
AS - Asia 13.330
SA - Sud America 2.650
AF - Africa 288
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 16
Totale 404.819
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 348.677
US - Stati Uniti d'America 27.236
CN - Cina 5.734
SG - Singapore 5.215
UA - Ucraina 4.004
BR - Brasile 2.257
SE - Svezia 2.241
NL - Olanda 1.284
DE - Germania 1.091
GB - Regno Unito 1.060
FI - Finlandia 1.006
VN - Vietnam 708
FR - Francia 533
KR - Corea 446
CA - Canada 393
IN - India 252
HK - Hong Kong 173
RU - Federazione Russa 163
AR - Argentina 142
BD - Bangladesh 98
TR - Turchia 98
ES - Italia 88
AU - Australia 83
MX - Messico 83
JP - Giappone 80
PL - Polonia 80
ID - Indonesia 77
ZA - Sudafrica 74
EC - Ecuador 72
IQ - Iraq 64
IR - Iran 56
MA - Marocco 53
BE - Belgio 50
CH - Svizzera 49
AT - Austria 48
IE - Irlanda 47
CO - Colombia 45
UZ - Uzbekistan 42
PK - Pakistan 39
EG - Egitto 36
RO - Romania 36
KE - Kenya 33
PY - Paraguay 33
VE - Venezuela 32
SA - Arabia Saudita 31
CL - Cile 30
NO - Norvegia 27
PH - Filippine 24
MY - Malesia 22
AE - Emirati Arabi Uniti 21
CZ - Repubblica Ceca 21
PE - Perù 19
IL - Israele 18
JO - Giordania 18
LT - Lituania 18
DK - Danimarca 16
DZ - Algeria 16
PT - Portogallo 15
SK - Slovacchia (Repubblica Slovacca) 14
EU - Europa 13
HR - Croazia 13
HU - Ungheria 13
UY - Uruguay 13
AZ - Azerbaigian 12
GR - Grecia 12
BG - Bulgaria 11
KZ - Kazakistan 11
MU - Mauritius 11
NZ - Nuova Zelanda 11
SN - Senegal 11
NG - Nigeria 10
TH - Thailandia 10
TN - Tunisia 10
TW - Taiwan 10
DO - Repubblica Dominicana 9
NP - Nepal 9
RS - Serbia 9
AL - Albania 8
EE - Estonia 8
JM - Giamaica 8
LB - Libano 8
PS - Palestinian Territory 8
GH - Ghana 7
GT - Guatemala 7
HN - Honduras 7
LV - Lettonia 7
OM - Oman 7
PA - Panama 7
AM - Armenia 6
BO - Bolivia 6
LU - Lussemburgo 6
CR - Costa Rica 5
ET - Etiopia 5
KW - Kuwait 5
MM - Myanmar 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
CI - Costa d'Avorio 4
IS - Islanda 4
AO - Angola 3
Totale 404.759
Salva come PNG Salva come JPEG
Città #
Cagliari 334.528
Uta 8.242
Singapore 2.635
Chandler 2.614
Boardman 2.238
Jacksonville 2.134
Dallas 2.047
Ashburn 1.871
Fairfield 1.865
Woodbridge 1.577
Ann Arbor 1.264
Amsterdam 1.098
Wilmington 1.049
Houston 1.003
Nyköping 966
Beijing 925
Hefei 766
Boston 710
Seattle 695
Nanjing 638
Cambridge 578
Milan 526
Los Angeles 504
Seoul 429
Rome 420
Buffalo 404
Helsinki 388
Dearborn 251
Ho Chi Minh City 238
Toronto 235
Santa Clara 234
New York 226
Shanghai 207
Shenyang 204
São Paulo 196
Nanchang 170
Tianjin 166
Changsha 160
Verona 160
Hong Kong 156
San Diego 155
Hebei 147
Jiaxing 139
The Dalles 136
Redwood City 124
Hanoi 123
Guangzhou 121
Dong Ket 114
Norwalk 113
Chicago 107
Orange 102
Jinan 87
Munich 83
Redondo Beach 78
Zhengzhou 78
London 77
Council Bluffs 73
Naples 73
Washington 73
Rio de Janeiro 71
Bologna 69
Florence 69
Ningbo 64
Phoenix 64
Warsaw 63
Brooklyn 62
Turin 60
Sassari 58
Frankfurt am Main 56
Cardiff 55
Nieuwegein 54
Saint Petersburg 54
Tokyo 54
Atlanta 53
Montreal 51
Bari 49
Belo Horizonte 49
Nuremberg 47
Pune 47
Brussels 43
Padova 42
Hangzhou 41
Johannesburg 41
Mountain View 41
Redmond 41
Torino 38
Brasília 37
Porto Alegre 37
Stockholm 36
Borås 35
Chennai 35
Orem 35
Millbury 34
San Francisco 34
Turku 34
Melbourne 33
Palermo 33
Parma 33
Tashkent 33
Curitiba 32
Totale 378.637
Salva come PNG Salva come JPEG
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.633
Violence and mental disorders. A retrospective study of people in charge of a community mental health center 4.451
Mortality in mental disorders: Are we approaching to close the gap respect to other medical specialties? The case of schizophrenia 4.204
Validation of the italian version of the compensatory eating and behaviors in response to alcohol consumption scale (CEBRACS) 4.197
Mental disorders in obese patients with and without metabolic syndrome 3.903
Psychopathology, psychosocial factors and obesity 3.821
The asthma-anxiety connection 3.696
Obesità, sindrome metabolica e comorbidità psichiatriche 3.673
Le psicoterapie 3.664
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 3.649
Obesità e qualità della vita 3.640
Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder 3.607
Role of palmitoylethanolamide (PEA) in depression: Translational evidence Special Section on “Translational and Neuroscience Studies in Affective Disorders”. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders 3.549
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.468
Challenges and Future Prospects of Precision Medicine in Psychiatry 3.398
Assessment of eating disorders with the diabetes eating problems survey - revised (DEPS-R) in a representative sample of insulin-treated diabetic patients: a validation study in Italy 3.357
Duration of untreated illness as a key to early intervention in schizophrenia: A review 3.162
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.100
Obesity, alexithymia and psychopathology: A case-control study 3.061
Mental disorders in patients with metabolic syndrome. The key role of central obesity 2.990
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 2.951
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.830
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.645
Clinical global impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders 2.640
Obesità e psicopatologia 2.637
Obesità, sindrome metabolica e comorbidità psichiatriche 2.615
Il modello alternativo del DSM-5 per i disturbi di personalità 2.609
Obesità e psicopatologia 2.596
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.568
Obesità, sindrome metabolica e comorbidità psichiatriche 2.548
Biomarkers in aggression 2.519
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.488
Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice 2.467
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 2.374
Obesità e alessitimia 2.366
Obesità e comorbidità psichiatrica di Asse I: risultati di uno studio caso – controllo 2.349
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.303
Diagnostic reliability in schizoaffective disorder 2.270
Disturbi da uso di sostanze e malattie dentali: lo stato dell’arte 2.135
The complex relationship between self-reported ‘personal recovery’ and clinical recovery in schizophrenia 2.012
Obesità e alessitimia 2.002
Psychiatric comorbidity and quality of life in obese patients. Results from a case-control study 1.977
Obesità, alessitimia e rappresentazione corporea: risultati di uno studio caso – controllo 1.961
Obesity and psychopathology. A study of psychiatric comorbidity among patients attending a specialist obesity unit 1.910
Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? Results of a retrospective study 1.898
Unblending borderline personality and bipolar disorders 1.878
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.866
Clinicians’ attitudes to cardiac function monitoring guidelines during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness 1.851
PALIPERIDONE PALMITATE IN ACUTE PATIENTS WITH SCHIZOPHRENIA - TREATMENT RESPONSE, SAFETY AND TOLERABILITY: A PROSPECTIVE FLEXIBLE DOSE STUDY IN PATIENTS PREVIOUSLY UNSUCCESSFULLY TREATED WITH ORAL ANTIPSYCHOTICS 1.818
Obesità e punteggi all’SCL-90-R 1.806
Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets 1.788
Mental health in transgender individuals: a systematic review 1.774
Disturbi dell'Umore 1.772
Asthma and psychiatric disorders 1.754
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses 1.658
Anatomical distribution and expression of CYP in humans: Neuropharmacological implications 1.636
Obesità e comorbidità psichiatrica di asse I: studio caso - controllo 1.626
Risk and resilience factors for specific and general psychopathology worsening in people with Eating Disorders during COVID-19 pandemic: a retrospective Italian multicentre study 1.625
Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups 1.620
First-episode psychosis and migration in Italy (PEP-Ita migration): A study in the Italian mental health services 1.612
Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives 1.599
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 1.594
Differenze di genere nella remissione e recovery di pazienti schizofrenici e schizoaffettivi: risultati di uno studio di coorte prospettico 1.579
Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups 1.575
Impulsivity and aggressiveness in bipolar disorder with co-morbid borderline personality disorder 1.544
The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review 1.543
The Italian version of the borderline personality disorder severity index IV: Psychometric properties, clinical usefulness, and possible diagnostic implications 1.534
Estimating the impact of workplace bullying: humanistic and economic burden among workers with chronic medical conditions 1.531
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis 1.528
Il disturbo bipolare e la comorbidità con i disturbi di personalità 1.495
Accuracy of self-assessment of real-life functioning in schizophrenia 1.467
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life” 1.452
Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study 1.446
The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia 1.443
Approccio al trattamento dell’obesità: 5 anni di esperienza in un team multidisciplinare metabolico - psicoeducazionale – motorio 1.442
Personalized psychiatry: Promises and pitfalls 1.442
How Is the History of Early Traumatic Exposure Associated With the Psychopathological Outcomes of COVID-19 Related Lockdown and Subsequent Re-opening in People With Eating Disorders? 1.429
Disturbo da sintomi somatici e disturbi correlati 1.424
Obesità e disturbi d’ansia 1.406
Editorial: Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/Pathways to Increase Treatment Efficacy 1.394
Obesità e ansia 1.391
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 1.390
Schizofrenia e disturbo schizoaffettivo: differenze cliniche, di decorso, esito e trattamento 1.355
Clinicians' adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: A retrospective report on 434 patients with severe mental illness 1.342
Obesità e qualità della vita 1.334
Big data in severe mental illness: the role of electronic monitoring tools and metabolomics 1.334
Disturbi della nutrizione e dell'alimentazione 1.325
The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future 1.317
Obesità e disturbi di personalità 1.316
Haloperidol and loss of gray matter in schizophrenia: Reconciling meta-analytical results with molecular pharmacology 1.316
The reciprocal relationship between suicidality and stigma 1.292
Pattern of gene expression in different stages of schizophrenia: Down-regulation of NPTX2 gene revealed by a meta-analysis of microarray datasets 1.280
Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia 1.271
Obesità e disturbi di personalità: risultati di uno studio caso - controllo 1.259
Prevalence and clinical correlates of cognitive symptoms in depression: A naturalistic study 1.242
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.211
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.211
Le cure 1.186
Obesità e disturbi di personalità 1.174
null 1.170
Totale 216.560
Salva come PNG Salva come JPEG
Categoria #
all - tutte 603.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 603.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135.869 0 0 0 0 0 9.390 7.434 5.169 2.062 4.690 4.469 2.655
2021/202220.439 2.074 1.744 1.090 1.523 1.842 1.450 973 905 1.419 1.601 2.815 3.003
2022/202333.545 2.927 2.859 2.970 2.628 2.664 3.452 1.397 6.784 2.294 1.687 2.351 1.532
2023/202444.625 2.576 1.506 2.647 4.157 3.964 7.633 6.465 3.063 2.217 3.347 3.666 3.384
2024/2025107.212 32.267 30.919 9.842 7.522 4.336 4.334 10.309 775 1.515 2.258 1.393 1.742
2025/202615.158 1.896 1.525 4.893 3.559 2.116 1.169 0 0 0 0 0 0
Totale 406.037